Role of Peritoneal Fluid Cytology in Gynaecological Cancers
Abstract
Intraperitoneal dissemination of disease is an important cause of morbidity and mortality among women with genital tract cancers.Peritoneal Fluid cytology is indispensable for diagnosis, prognosis,staging and ancillary studies in gynaecological Cancers. Peritoneal fluid was examined for the presence of tumor cells in 94 patients with ovarian and endometrial cancer. The findings were correlated with the type, grade, and stage of the tumor. Fluids that were positive for malignant cells were associated with serous and endometrioidcarcinomas of ovary more often than with carcinomas of other types. Patients with high-stage tumors of all types had positive fluids more often than those with low-stage tumors. The presence of tumor cells in the fluid indicated a worse prognosis at 2 years. Analysis of other factors that influence prognosis, however, revealed that this difference was related more specifically to the stage of the disease. Since the presence of tumor cells in abdominal fluid is a factor in the subclassification of Stage I and Stage II ovarian cancer, analysis of a larger group of patients with tumors in these stages is needed to establish the prognostic significance of positive cytological findings independent of other prognostic factors.
Downloads
References
Creasman WT, Rutledge F. The prognostic value of peritoneal cytology in gynecologic malignant disease.Am J Obstet Gynecol. 1971 Jul 15;110(6):773–781.
Keettel WC, Pixley EE, Buchsbaum HJ. Experience with peritoneal cytology in the management of gynecologic malignancies. Am J Obstet Gynecol. 1974 Sep 15;120(2):174–182.
Creasman WT, Disaia PJ, Blessing J, Wilkinson RH, Jr, Johnston W, Weed JC.,Jr Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol. 1981 Dec 15;141(8):921–929
Yazigi R, Piver MS, Blumenson L. Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer. Obstet Gynecol. 1983 Sep;62(3):359–362
DAHLE T. Transtubal spread of tumor cells in carcinoma of the body of the uterus. SurgGynecol Obstet. 1956 Sep;103(3):332–336.
HOEG K. Superficial dissemination of cancer of the uterine body; cytological examination of smears from the tubes and the pouch of Douglas. J ObstetGynaecol Br Emp. 1956 Dec;63(6):899–902.
Szpak CA, Creasman WT, Vollmer RT, Johnston WW. Prognostic value of cytologic examination of peritoneal washings in patients with endometrial carcinoma.ActaCytol. 1981 Nov-Dec;25(6):640–646.
Copyright (c) 2015 Acta Medica Scientia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
A) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
B) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
C) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
